![{[Name]}](https://resource.bocsci.com/structure/956348-61-1.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/2055104-86-2.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/propargyl-peg18-nhs-ester.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/2055105-25-2.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/2055022-22-3.gif?v=2025011501)
![{[Name]}](https://resource.bocsci.com/structure/propargyl-peg12-nhs-ester.gif?v=2025011501)
Inquiry Basket
Propargyl-PEG8-bromide | CAS 2055046-25-6
| Catalog Number | R01-0180 |
| Category | Alkynes |
| Molecular Formula | C19H35BrO8 |
| Molecular Weight | 471.38 |
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Product Introduction
Propargyl-PEG8-bromide features a terminal alkyne and bromide for versatile conjugation chemistry. Its long PEG8 spacer enhances hydrophilicity and is suitable for use in ADC linker strategies.
Chemical Information
Product Specification
Computed Properties
Patents
| Synonyms | Alkyne-PEG8-Br; Propargyl-PEG8-Br |
| Purity | >98.0% |
| Shelf Life | 0-4°C for short term (days to weeks), or -20°C for long term (months). |
| IUPAC Name | |
| Canonical SMILES | C#CCOCCOCCOCCOCCOCCOCCOCCOCCBr |
| InChI | InChI=1S/C19H35BrO8/c1-2-4-21-6-8-23-10-12-25-14-16-27-18-19-28-17-15-26-13-11-24-9-7-22-5-3-20/h1H,3-19H2 |
| InChIKey | GKKYPBWKHAGRKT-UHFFFAOYSA-N |
| Solubility | 10 mm in DMSO |
| Appearance | Solid |
| Storage | Store at -20 °C, keep in dry and avoid sunlight. |
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 24 |
| Exact Mass | 470.15153 g/mol |
| Monoisotopic Mass | 470.15153 g/mol |
| Topological Polar Surface Area | 73.8Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 337 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021050612-A1 | Compositions and methods for the treatment of respiratory syncytial virus | 2019-09-09 |
| WO-2020252396-A1 | Compositions and methods for the treatment of respiratory syncytial virus | 2019-06-13 |
Recommended Services
Recommended Articles
- Hoechst Dyes: Definition, Structure, Mechanism and Applications
- Mastering the Spectrum: A Comprehensive Guide to Cy3 and Cy5 Dyes
- Fluorescent Probes: Definition, Structure, Types and Application
- Fluorescent Dyes: Definition, Mechanism, Types and Application
- Coumarin Dyes: Definition, Structure, Benefits, Synthesis and Uses
- BODIPY Dyes: Definition, Structure, Synthesis and Uses
- Cyanine Dyes: Definition, Structure, Types and Uses
- Fluorescein Dyes: Definition, Structure, Synthesis and Uses
- Rhodamine Dyes: Definition, Structure, Uses, Excitation and Emission
- Unlocking the Power of Fluorescence Imaging: A Comprehensive Guide
- Cell Imaging: Definitions, Systems, Protocols, Dyes, and Applications
- Lipid Staining: Definition, Principles, Methods, Dyes, and Uses
- Flow Cytometry: Definition, Principles, Protocols, Dyes, and Uses
- Nucleic Acid Staining: Definition, Principles, Dyes, Procedures, and Uses
- DNA Staining: Definition, Procedures, Benefits, Dyes and Uses
- Cell Staining: Definition, Principles, Protocols, Dyes, and Uses
- Ion Imaging: Definition, Principles, Benefits, Dyes, and Uses
- Fluorescent Labeling: Definition, Principles, Types and Applications
Recommended Products
Online Inquiry
